Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Repeat inhaled GW870086X once daily vs placebo in mild to moderate asthma (crossover)
2008-008254-23Phase 2Completed
- Sponsor
- GSK
- Start
- Mar 2009
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial of GW870086 in asthma (2 arms), sponsored by GSK. Primary endpoint: Change from baseline in FEV1 on Day 28. Started Mar 2009; status: completed.
02
Drugs
GW870086
03
Conditions
asthma
Beyond the preview
Go deeper on 2008-008254-23.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2008-008254-23.